This video is sponsored by the Duke Clinical Medical Series.
* The Usefulness of Registries...
* What Interventional Cardiology...
* Major Adverse Cardiac...
* Relationship of MACE and ST
* Limitations of Registries
* Impact of FU Angiography
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, Dr. Philip Urban, has indicated that he is a consultant for Cordis,
Terumo, and Boston Scientific.